Menu

Multipurpose Prevention Technologies: Call for Innovative Strategies to Address Critical Priorities and Gaps

Multipurpose prevention technologies (MPTs) are innovative products designed to deliver combinations of HIV and other STI preventatives, and/or contraception. This special issue of Frontiers in Reproductive Health, co-edited by topic editor Bethany Young Holt of PHI’s CAMI Health, calls for expanding the MPT field in alignment with the identified MPT field-wide action areas.

graphic of microscope and multiprevention technologies

The HIV/sexually transmitted infection (STI) syndemics and the unmet need for modern contraceptive methods continue to pose significant health risks for women and other people worldwide. Multipurpose prevention technologies (MPTs) offer a potential solution: innovative reproductive health products that can deliver combinations of HIV and other STI preventatives, and/or contraception.

“Multipurpose Prevention Technologies: Call for Innovative Strategies to Address Critical Priorities and Gaps” is a Frontiers in Reproductive Health special issue, featuring a collection of 13 papers from MPT product developers and other stakeholders within and external to the MPT field to stimulate strategic thinking and action needed to expand the MPT field. PHI’s Bethany Young Holt is a topic editor.

The special issue includes the editorial “Multipurpose prevention technologies: Call for innovative strategies to address critical priorities and gaps,” co-authored and edited by staff from PHI’s CAMI Health. This editorial serves as an introduction to the full special issue: it provides an overview of challenges to MPT development including market conditions, regulatory hurdles and funding, as well as exploring five field-identified priority areas for MPT development.

see the full special issue Read the editorial

 

The additional papers in this special issue are organized around these five priority areas; they provide updates, lessons learned, and discussion around what the MPT field can do in order to continue advancing product development and distribution in an efficient and equitable manner.

Priority areas for MPT development include:

  1. A productive ecosystem of MPT product R&D
  2. Improved understanding of reproductive biology for the purpose of new pharmaceutical development for MPT R&D
  3. Expanded understanding of socio-behavioral research (SBR) considerations among underrepresented groups in MPT research
  4. Expanded understanding of market considerations to help ensure successful commercialization and uptake of MPTs
  5. Enhanced understanding of innovative approaches for MPT clinical trials that address regulatory and ethical challenges of testing multiple indications in the same trial

“To realize the full potential of MPTs, we must strategically work to move promising products from the laboratory to end-users, improving the diverse health needs and wants of women globally.” – Frontiers in Reproductive Health editorial: Multipurpose prevention technologies: call for innovative strategies to address critical priorities and gaps

Originally published by Frontiers in Reproductive Health

Additional Contributors

  • Clara Soh
  • Ariane van der Straten
  • Anke Hemmerling
  • Jim A. Turpin
  • Bethany Young Holt
  • Moushira El-Sahn
  • Kate Segal
  • Jocelyn Major
  • Sarah Dohadwala
  • Joseph Politch
  • Deborah Jean Anderson
  • Steven Forsythe
  • Urbanus Kioko
  • Robert Glaubius
  • Abednego M. Musau
  • Jason Bailey Reed
  • Daniel Were
  • Heather Vahdat
  • Logan Nickels
  • Caroline Murombedzi
  • Libert Chirinda
  • Gift Chareka
  • Z Mike Chirenje
  • Nyaradzo Mavis Mgodi
  • Katerina Chapman
  • Elijah Kahn-Woods
  • Gabriela Gomez
  • Mary Latka
  • Anita Dam
  • Alison Kutywayo
  • Paballo Mataboge
  • Nqaba Mthimkhulu
  • Catherine Martin
  • Lorrein Muhwava-Mbabala
  • Mbali Mazibuko
  • Nthabiseng Rejoice Makalela
  • Khanyiswa Kwatsha
  • Vusile Butler
  • Saiqa Mullick
  • James Cummins
  • C. Leigh Allen
  • Sonia Lee
  • Theresa Senn
  • Anne-Isabelle Cameron
  • Cherise Scott
  • Taryn Barker
  • Rose Elliott
  • Mona El-Sahn
  • Jeff Lucas
  • Trisha Wood Santos
  • Wawira Nyagah
  • Jess Feltham
  • Alex Ash
  • Moowa Masani
  • Matthew T. Geib
  • Guy Mahiane
  • Anthony Gichangi
  • Sergio Torres-Rueda
  • Mutsumi Metzler
  • Douglas Thornton
  • Wawira Nyagah
  • Jess Feltham
  • Alex Ash
  • Moowa Masani
  • Kristin Vahle
  • Kevin Li
  • Megan Gomes
  • Carmen Pérez-Casas

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Close

PHI's Top 24 Impacts for 2024

During 2024, PHI worked alongside our partners to advance public health research, policies, programs and interventions in communities around the globe. Explore some of our most impactful work in 2024—a collection of our top stories, tools, resources and ideas that helped to improve health, advance equity and build community power.

See the impacts

Continue to PHI.org